Yahoo India Web Search

Search results

    • 5 FDA decisions to watch in the third quarter

      5 FDA decisions to watch in the third quarter

      BioPharma Dive· 13 hours ago

      Multibillion-dollar buyouts from Bristol Myers Squibb and Gilead could yield new drugs for brain and liver diseases, while a new cell therapy may reach...